Nicorette Mint 2 mg lozenges

Nicorette is a leading global brand specializing in nicotine replacement therapy (NRT) products. The brand's history began in Helsingborg, Sweden, where it was originally developed by the company AB Leo. Over the decades, Nicorette has become instrumental in helping individuals quit smoking by providing controlled doses of nicotine to manage withdrawal symptoms.

The manufacturing of many Nicorette products, including lozenges (sugtabletter) and gums, remains primarily centered in Helsingborg, Sweden, which serves as a global hub for the brand. Following various corporate mergers and acquisitions, the brand transitioned from Pharmacia to Pfizer, and eventually to Johnson & Johnson. As of the early 2020s, Johnson & Johnson spun off its consumer health division into a new independent company called Kenvue. Therefore, Kenvue is the ultimate owner and global manager of the Nicorette brand, maintaining its strong presence in the Swedish and international healthcare markets.